These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556 [TBL] [Abstract][Full Text] [Related]
24. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Ahmad N; Cheng P; Mukhtar H Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666 [TBL] [Abstract][Full Text] [Related]
25. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Wang Y; Zhang H; Holmgren A; Tian W; Zhong L Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731 [TBL] [Abstract][Full Text] [Related]
27. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Yang F; Oz HS; Barve S; de Villiers WJ; McClain CJ; Varilek GW Mol Pharmacol; 2001 Sep; 60(3):528-33. PubMed ID: 11502884 [TBL] [Abstract][Full Text] [Related]
28. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Yamauchi R; Sasaki K; Yoshida K Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223 [TBL] [Abstract][Full Text] [Related]
29. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Wang YC; Bachrach U Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181 [TBL] [Abstract][Full Text] [Related]
30. [Telomere and telomerase in human cancer]. Hiyama K; Hiyama E; Ishioka S; Yamakido M Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230 [TBL] [Abstract][Full Text] [Related]
31. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043 [TBL] [Abstract][Full Text] [Related]
32. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027 [TBL] [Abstract][Full Text] [Related]
33. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides. Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922 [TBL] [Abstract][Full Text] [Related]
34. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells. Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Kuzuhara T; Tanabe A; Sei Y; Yamaguchi K; Suganuma M; Fujiki H Mol Carcinog; 2007 Aug; 46(8):640-5. PubMed ID: 17440927 [TBL] [Abstract][Full Text] [Related]
36. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619 [TBL] [Abstract][Full Text] [Related]
37. Experimental study on anti-neoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas. Ran ZH; Zou J; Xiao SD Chin Med J (Engl); 2005 Aug; 118(16):1330-7. PubMed ID: 16157026 [TBL] [Abstract][Full Text] [Related]
38. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Lee WJ; Shim JY; Zhu BT Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419 [TBL] [Abstract][Full Text] [Related]
40. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Chen Z; Koeneman KS; Corey DR Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]